Eloxx Pharmaceuticals, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 11/08/2026 | Mar 2026Filed 11/08/2026 | Jun 2025Filed 11/08/2026 | Mar 2025Filed 11/08/2026 | Sep 2023Filed 13/11/2023 | Jun 2023Filed 13/11/2023 | Mar 2023Filed 13/11/2023 | Sep 2022Filed 13/11/2023 |
|---|---|---|---|---|---|---|---|---|
| −$4.5 | −$3.8 | −$1.9 | −$1.7 | −$3.6 | −$4.3 | −$6.2 | −$7.5 | |
| −$0.66 | −$0.86 | −$5.45 | −$4.94 | −$1.31 | −$1.96 | −$2.88 | −$3.47 | |
| 6.8 | 4.4 | 0.3 | 0.3 | 2.7 | 2.2 | 2.2 | — |
Trend